The Severe Chronic Neutropenia International Registry: 10-Year follow-up report

Supportive Cancer Therapy

Volumn 3, Issue 4, 2006, Pages 220-231

  Dale, David C ^a   Bolyard, Audrey Anna ^a   Schwinzer, Beate G ^b   Pracht, Gusal ^b   Bonilla, Mary Ann ^c   Boxer, Laurence ^d   Freedman, Melvin H ^e   Donadieu, Jean ^f   Kannourakis, George ^g   Alter, Blanche P ^h   Cham, Bonnie P ⁱ   Winkelstein, Jerry ^j   Kinsey, Sally E ^k   Zeidler, Cornelia ^b   Welte, Karl ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f ARMAND TROUSSEAU HOSPITAL   (France)

^g Ballarat Oncology and Haematology Services   (Australia)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ CANCERCARE MANITOBA   (Canada)

^j JOHNS HOPKINS HOSPITAL   (United States)

^k ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

more..

Author keywords

Granulocytopenia; Immune deficiency; Leukopenia; Recurrent infection

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; GEOGRAPHIC DISTRIBUTION; HEMATOLOGIC DISEASE; HUMAN; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NEUTROPENIA; NEUTROPHIL COUNT; OSTEOPENIA; OSTEOPOROSIS; QUALITY OF LIFE; SHWACHMAN SYNDROME;

EID: 33749478463     PISSN: 15432912     EISSN: None     Source Type: Journal    
DOI: 10.3816/SCT.2006.n.020     Document Type: Conference Paper

References (107)

1. Dale DC. Neutropenia and neutrophilia. In: Lichtman MS, Kipps TJ, Kauschansky K, et al, eds. Williams Hematology. 7th ed. New York; McGraw-Hill; 2006:907-920.
2. Boxer L, Dale DC. Neutropenia: causes and consequences. Semin Hematol 2002; 39:75-81.
3. Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol 2002; 39:82-88.
4. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72:82-93.
5. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989; 320:1574-1580.
6. Jakubowski AA, Souza L, Kelly F, et al. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med 1989; 320:38-42.
7. Hammond WP IV, Price TH, Souza LM, et al. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 1989; 320:1306-1311.
8. Welte K, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990; 75:1056-1063.
9. Donadieu J, Boutard P, Tchernia G, et al. A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in children. Nouv Rev Fr Hematol 1994; 6:441-448.
10. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human G-CSF for treatment of severe chronic neutropenia. Blood 1993; 181:2496-2502.
11. Bellanne-Chantelot C, Clauin S, Leblanc T, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 2004; 103:4119-4125.
12. Cassinat B, Bellanne-Chantelot C, Notz-Carrere A, et al. Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French Neutropenia Register. Leukemia 2004; 18:1553-1555.
13. Petitti DB, Contreras R, Glowalla M, et al. Most severe neutropenia in individuals with no chronic condition did not result in a specific diagnosis. J Clin Epidemiol 2004; 57:1182-1187.
14. Zeidler C, Boxer L, Dale DC, et al. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000; 109:490-495.
15. Palmer SE, Dale DC, Livingston RJ, et al. Exclusion of the gene for autosomal dominant cyclic hematopoiesis from chromosome 5 by genetic linkage analysis. Hum Genet 1994; 93:195-197.
16. Dale DC, Bolyard AA, Aprikyan A. Cyclic neutropenia. Semin Hematol 2002; 39:89-94.
17. Kyle RA, Linman JW. Chronic idiopathic neutropenia. A newly recognized entity? N Engl J Med 1968; 279:1015-1019.
18. Papadaki HA, Eliopoulos AG, Kosteas T, et al. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood 2003; 101:2591-2600.
19. Rezvani K, Flanagan AM, Sarma U, et al. Investigation of ethnic neutropenia by assessment of bone marrow colony-forming cells. Acta Haematol 2001; 105:32-37.
20. Bonilla MA, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (rmetHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994; 88:723-730.
21. Frampton JE, Lee CR, Faulds D. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 1994; 48:731-760.
22. Mori PG, Pasino M, Dufour C, et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia. Blood 1994; 84:3244-3245.
23. Rosenberg PS, Alter BP, Bolyard AA, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2005; 106:197a (Abstract #669).
24. Dror Y, Ward AC, Touw IP, et al. Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: activated glucocorticoid receptors synergize with G-CSF signals. Exp Hematol 2000; 28:1381-1389.
25. Choi SW, Boxer LA, Pulsipher MA, et al. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation. Bone Marrow Transplant 2005; 35:473-7.
26. Nakazawa Y, Sakashita K, Kinoshita M, et al. Successful unrelated cord blood transplantation using a reduced-intensity conditioning regimen in a 6-month-old infant with congenital neutropenia complicated by severe pneumonia. Int J Hematol 2004; 80:287-290.
27. Ferry C, Ouachee M, Leblanc T, et al. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant 2005; 35:45-50.
28. Mino E, Kobayashi R, Yoshida M, et al. Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia. Bone Marrow Transplant 2004; 33:969-971.
29. Dallorso S, Manzitti C, Dodero P, et al. Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndrome and long-lasting invasive pulmonary mycosis. Eur J Haematol 2003; 70:322-325.
30. Toyoda H, Azuma E, Hori H, et al. Successful unrelated BMT in a patient with Kostmann syndrome complicated by pre-transplant pulmonary "bacterial" abscesses. Bone Marrow Transplant 2001; 28:413-415.
31. Jeha S, Chan KW, Aprikyan AG, et al. Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. Blood 2000; 96:3647-3649.
32. Zeidler C, Welte K, Barak Y, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95:1195-1198.
33. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, et al, eds. Hematology of Infancy and Childhood. Philadelphia, PA: W.B. Saunders Inc; 2003:280-365.
34. Miller RW. Childhood cancer and congenital defects. A study of U.S. death certificates during the period 1960-1966. Pediatr Res 1969; 3:389-397.
35. Gilman PA, Jackson DP, Guild HG. Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood 1970; 36:576-585.
36. Rosen RB, Kang SJ. Congenital agranulocyrosis terminating in acute myelomonocytic leukemia. J Pediatr 1979; 94:406-408.
37. Wong WY, Williams D, Slovak ML, et al. Terminal acute myelogenous leukemia in a patient with congenital agranulocytosis. Am J Hematol 1993; 43:133-138.
38. Waites MD, Roberts JV, Scott-Coombes D, et al. Cyclic neutropenia and pyomyositts: a rare cause of overwhelming sepsis. Ann R Coll Surg Engl 2002; 84:26-28.
39. Bar-Joseph G, Halberthal M, Sweed Y, et al. Clostridium septicum infection in children with cyclic neutropenia. J Pediatr 1997; 131:317-319.
40. Goldschneider KR, Forouhar FA. Cyclic neutropenia: a case of asymptomatic appendicitis [published erratum in Ann Clin Lab Sci 1990; 20:300]. Ann Clin Lab Sci 1989; 19:429-434.
41. Haghshenas M, Banihashemi A, Mohallatee EA. Cyclic neutropenia. Blut 1974; 28:199-201.
42. Geelhoed GW, Kane MA, Dale DC, et al. Colon ulceration and perforation in cyclic neutropenia. J Pediatr Surg 1973; 8:379-382.
43. Megalakaki A, Mitsouli C, Pontikoglou C, et al. Chronic idiopathic neutropenia preceding polymyalgia rheumatica and acute myeloid leukemia. Ann Hematol 2004; 83:791-792.
44. Papadaki HA, Kosteas T, Gemetzi C, et al. Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia. Ann Hematol 2004; 83:345-348.
45. Freedman MH, Alter BP. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin Hematol 2002; 39:128-133.
46. Auner HW, Klintschar M, Crevenna R, et al. Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukaemia. Br J Haematol 1999; 105:431-433.
47. Melis D, Fulceri R, Parenti G, et al. Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature. Eur J Pediatr 2005; 164:501-508.
48. Barth PG, Valianpour F, Bowen VM, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet A 2004; 126:349-351.
49. Dror Y. Shwachman-Diamond syndrome. Pediatr Blood Cancer 2005; 45:892-901. Review.
50. Cottle TE, Fier CJ, Donadieu J, et al. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Semin Hematol 2002; 39:134-140.
51. Zeidler C, Schwinzer B, Welte K. Congenital neutropenias. Rev Clin Exp Hematol 2003; 7:72-83.
52. Elhasid R, Hofbauer LC, Ish-Shalom S, et al. Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. Am J Hematol 2003; 72:34-37.
53. Smith MA, Smith JG. Clinical experience with the use of rhG-CSF in secondary autoimmune neutropenia. Clin Lab Haematol 2002; 24:93-97.
54. Yakisan E, Schirg E, Zeidler C, et al. High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome). J Pediatr 1997; 131:592-597.
55. Simon M, Lengfelder E, Reiter S, et al. Osteoporosis in severe congenital neutropenia: inherent to the disease or a sequela of G-CSF treatment? Am J Hematol 1996; 52:127.
56. Bishop NJ, Williams DM, Compston JC, et al. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor [published erratum in Br J Haematol 1995; 90:492]. Br J Haematol 1995; 89:927-928.
57. Donadieu J, Leblanc T, Bader Meunier B, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005; 90:45-53.
58. White C, Chen Z, Raetz E, et al. Using fluorescence-activated cell sorting followed by fluorescence in situ hybridization to study lineage relationships: the 8;21 translocation is present in neutrophils but not monocytes in a patient with severe congenital neutropenia and a granulocyte colony-stimulating factor-responsive clonal abnormality. Acta Paediatr Suppl 2002; 91:120-123.
59. Touw IP, Dong F. Severe congenital neutropenia terminating in acute myeloid leukemia: disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene. Leuk Res 1996; 20:629-631.
60. Kalra R, Dale D, Freedman M, et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 1995; 86:4579-4586.
61. Weinblatt ME, Scimeca P, James-Herry A, et al. Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child tteated with granulocyte colony-stimulating factor. J Pediatr 1995; 126:263-265.
62. Imashuku S, Hibi S, Kataoka-Morimoto Y, et al. Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. Br J Haematol 1995; 89:188-190.
63. Germeshausen M, Schulze H, Kratz C, et al. An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia. Leukemia 2005; 19:611-617.
64. Lensink DB, Barton A, Appelbaum FR, et al. Cyclic neutropenia as a premalignant manifestation of acute lymphoblastic leukemia. Am J Hematol 1986; 22:9-16.
65. Dong F, Hoefsloot LH, Schelen AM, et al. Identification of a non-sense mutation in the granulocyte-colony-stirnulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 1994; 91:4480-4484.
66. Tidow N, Pilz C, Kasper B, et al. Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy. Stem Cells 1997; 15(suppl 1):113-119.
67. Tidow N, Pilz C, Teichmann B, et al. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 1997; 89:2369-2375.
68. Dong F, Dale DC, Bonilla MA, et al. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 1997; 11:120-125.
69. Ward AC, van Aesch YM, Gits J, et al. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. J Exp Med 1999; 190:497-507.
70. Herbst A, Koester M, Wirth D, et al. G-CSF receptor mutations in patients with severe congenital neutropenia do not abrogate Jak2 activation and stat1/stat3 translocation. Ann N Y Acad Sci 1999; 872:320-325.
71. Ward AC, van Aesch YM, Schelen AM, et al. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood 1999; 93:447-458.
72. Dong F, Qiu Y, Yi T, et al. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J Immunol 2001; 167:6447-6452.
73. Germeshausen M, Ballmaier M, Weite K. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias. Ann N Y Acad Sci 2001; 938:305-320.
74. Ancliff PJ, Gale RE, Liesner R, et al. Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. Br J Haematol 2003; 120:685-690.
75. Sinha S, Zhu QS, Romero G, et al. Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia refractory to granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 2003; 25:791-796.
76. Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999; 23:433-436.
77. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96:2317-2322.
78. Schiller M, Bohm M, Zeidler C, et al. Cyclic neutropenia. Detection of a mutation in the gene for neutrophil elastase (ELA2). Hautarzt 2001; 52:790-796.
79. Sera Y, Kawaguchi H, Nakamura K, et al. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia. Haematologica 2005; 90:1032-1041.
80. Li DY, Scheimann AO, Songer JG, et al. Enteriris necroticans with recurrent enterocutaneous fistulae caused by Clostridium perfringens in a child with cyclic neutropenia. J Pediatr Gastroenterol Nutr 2004; 38:213-215.
81. Germeshausen M, Schulze H, Ballmaier M, et al. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br J Haematol 2001; 115:222-224.
82. Hakki SS, Aprikyan AA, Yildirim S, et al. Periodontal status in two siblings with severe congenital neutropenia: diagnosis and mutational analysis of the cases. J Periodontol 2005; 76:837-844.
83. Ancliff PJ. Congenital neutropenia. Blood Rev 2003; 17:209-216.
84. Ancliff PJ, Gale RE, Linch DC. Neutrophil elastase mutations in congenital neutropenia. Hematology 2003; 8:165-171.
85. Ancliff PJ, Gale RE, Liesner R, et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001; 98:2645-2650.
86. Ancliff PJ, Gale RE, Watts MJ, et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood 2002; 100:707-709.
87. Boxer LA, Stein S, Buckley D, et al. Unique evidence for autosomal dominant inheritance of severe congenital neutropenia. Journal of Peds. In Press.
88. Sera Y, Kawaguchi H, Nakamura K, et al. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia. Haematologica 2005; 90:1032-1041.
89. Massullo P, Druhan LJ, Bunnell BA, et al. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood 2005; 105:3397-3404.
90. Papadaki HA, Eliopoulos GD. The role of apoptosis in the pathophysiology of chronic neutropenias associated with bone marrow failure. Cell Cycle 2003; 2:447-451.
91. Aprikyan AA, Kutyavin T, Stein S, et al. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol 2003; 31:372-381.
92. Carlsson G, Aprikyan AA, Tehranchi R, et al. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004; 103:3355-3361.
93. Cario G, Skokowa J, Wang Z, et al. Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol 2005; 129:275-278.
94. Koumaki V, Papadaki HA, Stefanaki K, et al. Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia. Ann Hematol 2003; 82:641-645.
95. Ramirez MJ, Titos E, Claria J, et al. Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites. J Hepatol 2004; 41:44-48.
96. Salmen S, Teran G, Borges L, et al. Increased Fas-mediated apoptosis in polymorphonuclear cells from HIV-infected patients. Clin Exp Immunol 2004; 137:166-172.
97. Aref S, El Refaei MF, Sakrana M, et al. Enhanced neutrophil apoptosis in neutropenic patients with hepatosplenic schistosomiasis: evidence of serum Fas ligand. Hematology 2004; 9:71-78.
98. Debatin KM. Role of apoptosis in congenital hematologic disorders and bone marrow failure. Rev Clin Exp Hematol 2003; 7:57-71.
99. Koumaki V, Papadaki HA, Stefanaki K, et al. Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia. Ann Hematol 2003; 82:641-645.
100. Kuijpers TW, Maianski NA, Tool AT, et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 2003; 101:5021-5024.
101. Nwakoby IE, Reddy K, Patel P, et al. Fas-mediated apoptosis of neutrophils in sera of patients with infection. Infect Immun 2001; 69:3343-3349.
102. Aprikyan AA, Liles WC, Park JR, et al. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 2000; 95:320-327.
103. Courtney PA, Crockard AD, Williamson K, et al. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58:309-314.
104. Aref S, Refaei ME, Goda T, et al. Accelerated neutrophil apoptosis in neutropenic patients with hepatosplenic schistosomiasis is induced by serum Fas ligand. Hematol J 2004; 5:434-439.
105. Head DR, Boxer LA, Bolyard AA, et al. Morphologic assessment of marrow aspirates in severe congenital neutropenia (CN) fails to predict evolution to myelodysplastic syndrome (MDS) and acute myeloblastic leukemia (AML). Blood 1999; 94:430a.
106. Stein S, Makaryan V, Zhu Q, et al. The frequency of mutations of the genes for neutrophil elastase, proteinase 3, Wiskott-Aldrich protein, and GFl-1 in patients with severe congenital neutropenia. Blood 2003; 102:274a (Abstract #972).
107. Dale DC, Stein S. The molecular basis and therapy of disorders associated with chronic neutropenia. Curr Allergy Asthma Rep 2003; 3:385-388.